A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALS
Study sponsor: Alector Inc. · ALEC
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-10-28Actual
Enrollment · participants5Actual
Source updated2025-06-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.